University of Michigan

The University of Michigan’s programs consistently places high in national rankings. Especially renowned are the Stephen Ross School of Business, the College of Engineering, The Law and Medical Schools, and the Musical Theatre program. There is also a strong film presence in Ann Arbor, with many major motion pictures being shot there and the annual Ann Arbor Film Festival, which brings in filmmakers from all over the world.

Michael Psarouthakis

Director, Michigan Venture Center

20 past transactions

Rescale

Series D in 2025
Rescale, Inc. is a company that specializes in developing and operating cloud-based platforms for scientific and engineering simulations. Its offerings include the ScaleX Pro platform for independent professionals and small to medium-sized businesses, and ScaleX Developer, which allows external application developers to integrate their software directly with Rescale’s systems. Additionally, the ScaleX Enterprise platform provides a comprehensive solution for enterprise-level simulation needs, managing on-premise high-performance computing resources and software licenses. Serving a diverse range of industries, including aerospace, automotive, and life sciences, Rescale facilitates more than 300 customers, from startups to large corporations, in accelerating their design processes and reducing time to market. Founded in 2011 and headquartered in San Francisco, Rescale also has offices in Tokyo, Munich, and Singapore, and it is supported by a variety of investors from the technology and venture capital sectors.

Infinium

Series C in 2025
Infinium is a provider of electrofuels that produces synthetic fuels from renewable energy and waste carbon dioxide. The company's ultra-low carbon electrofuels serve as drop-in replacements for traditional petroleum-derived products, allowing for immediate integration into existing transportation systems and chemical processes, such as plastics production. This approach significantly reduces greenhouse gas emissions and helps clients meet carbon reduction targets without the need for extensive capital investment or time-consuming upgrades. Through its innovative solutions, Infinium aims to decarbonize the transportation sector and contribute to a more sustainable future.

Stoke Space

Series C in 2025
Stoke Space is dedicated to developing a fully reusable medium-lift rocket named Nova, aimed at providing cost-effective and sustainable access to space. The company focuses on creating rockets that can be reused multiple times, offering low-cost, on-demand launch services designed for daily operations. By emphasizing sustainability, Stoke Space seeks to reduce the atmospheric impact of space missions while supporting the growth of the space economy. Their vertically integrated design and manufacturing capabilities enable them to deliver reliable solutions for clients looking to launch satellites efficiently and sustainably.

X-energy

Series C in 2024
X-energy is a developer of advanced modular nuclear reactors and fuel technology for clean energy generation. The company manufactures fuel that seals uranium particles in a protective coating, making meltdown impossible. It develops safe and efficient reactors and proprietary fuel to deliver reliable, zero-carbon, affordable energy to people worldwide. The simplified, modular, and high-temperature gas reactor design expands applications and markets for the deployment of nuclear technology.

Stoke Space

Series B in 2023
Stoke Space is dedicated to developing a fully reusable medium-lift rocket named Nova, aimed at providing cost-effective and sustainable access to space. The company focuses on creating rockets that can be reused multiple times, offering low-cost, on-demand launch services designed for daily operations. By emphasizing sustainability, Stoke Space seeks to reduce the atmospheric impact of space missions while supporting the growth of the space economy. Their vertically integrated design and manufacturing capabilities enable them to deliver reliable solutions for clients looking to launch satellites efficiently and sustainably.

ModernVivo

Convertible Note in 2023
ModernVivo is a company that specializes in developing a software platform aimed at improving the drug development process for pharmaceutical companies. Recognizing that 90% of new drugs fail in clinical trials often due to ineffective preclinical animal studies, ModernVivo provides tools that enhance the design of in-vivo protocols. By streamlining the protocol-writing process, which has traditionally been time-consuming and prone to errors, the platform enables scientists to create optimized preclinical models more efficiently. This innovation not only assists researchers in generating reliable data but also aims to accelerate drug development timelines and reduce associated costs, ultimately increasing the chances of clinical success for new therapies.

ModernVivo

Grant in 2022
ModernVivo is a company that specializes in developing a software platform aimed at improving the drug development process for pharmaceutical companies. Recognizing that 90% of new drugs fail in clinical trials often due to ineffective preclinical animal studies, ModernVivo provides tools that enhance the design of in-vivo protocols. By streamlining the protocol-writing process, which has traditionally been time-consuming and prone to errors, the platform enables scientists to create optimized preclinical models more efficiently. This innovation not only assists researchers in generating reliable data but also aims to accelerate drug development timelines and reduce associated costs, ultimately increasing the chances of clinical success for new therapies.

ModernVivo

Grant in 2022
ModernVivo is a company that specializes in developing a software platform aimed at improving the drug development process for pharmaceutical companies. Recognizing that 90% of new drugs fail in clinical trials often due to ineffective preclinical animal studies, ModernVivo provides tools that enhance the design of in-vivo protocols. By streamlining the protocol-writing process, which has traditionally been time-consuming and prone to errors, the platform enables scientists to create optimized preclinical models more efficiently. This innovation not only assists researchers in generating reliable data but also aims to accelerate drug development timelines and reduce associated costs, ultimately increasing the chances of clinical success for new therapies.

Genomenon

Series B in 2022
Genomenon develops software tools to rapidly and autonomously prioritize data points for decision-making. It revolutionizes the way genetic diagnoses and discoveries are made. The company’s suite of diagnostic and discovery tools enable physicians, pharma, and researchers to quickly and accurately identify disease-causing variants from genomic-sequencing datasets. It was founded in 2014 and is headquartered in Ann Arbor, Michigan.

Parcel Health

Pre Seed Round in 2021
Parcel Health is dedicated to revolutionizing medication packaging by offering the world's first fully brandable and compostable paper-based prescription bottle. This innovative product aims to replace traditional plastic bottles, contributing to sustainability efforts and helping pharmacies and pharmaceutical companies achieve carbon neutrality goals. Parcel Health's packaging not only enhances the safety and integrity of medications during shipping but also improves logistical efficiency, minimizing in-transit damage and bolstering customer satisfaction. Designed to be child-resistant and elder-friendly, the company’s solutions improve pharmacy workflows and reduce medication errors, positioning Parcel Health as a leader in eco-friendly pharmaceutical packaging.

LineLeap

Pre Seed Round in 2019
LineLeap is focused on enhancing the nightlife experience by offering a platform that simplifies access to various services at bars and clubs. Users can purchase LineSkip passes, cover charges, reservations, event tickets, and drinks directly from their phones, allowing for a more convenient and enjoyable night out. The platform also features exclusive deals from partnered venues across the United States, aiming to create a seamless experience for customers. Additionally, LineLeap supports venue owners by improving customer service and marketing efforts, while also introducing new revenue opportunities. Ultimately, LineLeap strives to make nightlife hassle-free, fun, and efficient for both patrons and venue operators.

Ecovia Renewables

Seed Round in 2018
Ecovia Renewables Inc. was formed in 2014 as a spin-out company from the University of Michigan. It is our mission to develop and commercialize high-performing biobased ingredients and materials from sustainable processes at the best value for our customers. We do this by having microbial ecosystems work for us. Our suite of Ecovia™ Biopolymers are created from a proprietary fermentation process. They are affordable, biobased, biodegradable, and functional alternatives to conventional acrylate and acrylamide polymers and starch-based biopolymers. Applications range from soil additives for water retention to super-absorbent cores for infant diapers to thickeners for personal care and industrial products, among many others.

Matterhorn

Series A in 2017
Matterhorn, developed by Court Innovations, is a cloud-based online platform designed to facilitate case resolution for courts and users. It allows individuals to select their court, search for their case, check status updates, and resolve issues online, streamlining the process for handling high-volume infractions and minor disputes. By providing online negotiation systems and resolution options, Matterhorn empowers defendants to address minor violations informally and conveniently, reducing the need for legal representation. This innovative approach not only saves time and resources for both citizens and courts but also promotes equitable decision-making in the judicial process. Matterhorn primarily serves customers in Michigan and Ohio, helping to enhance the efficiency of court operations since its founding in 2014 by J.J. Prescott, with headquarters located in Ann Arbor, Michigan.

Securus Medical Group

Series C in 2016
Securus Medical Group engages in the development of clinical tools to improve the safety and efficacy of ablation therapy by providing real-time, non-contact, high-resolution tissue temperature monitoring, and mapping products. The company engages in developing real-time, noncontact, thermal mapping systems to determine intrabody tissue temperatures.

PreDxion Bio

Grant in 2016
PreDxion Bio is an early-stage healthcare company revolutionizing testing and treatment through low-cost, user-friendly at-home diagnostics. Enabled by PreDxion’s proprietary multiplexed localized surface plasmon resonance (LSPR) technology, our first product is a rapid, saliva-based test for COVID-19, flu, pneumonia, common cold, and other respiratory diseases.

Crossbar

Series D in 2015
Crossbar Inc. specializes in developing and licensing resistive RAM (ReRAM) technology, which offers innovative non-volatile memory solutions for various applications. Founded in 2008 and headquartered in Santa Clara, California, the company’s technology enables the storage of up to one terabyte of data on a chip the size of a postage stamp, providing high performance with low power consumption. Crossbar's ReRAM is designed for use in consumer electronics, mobile devices, enterprise storage systems, and IoT applications such as smart meters and industrial sensors. By allowing for integrated compute and storage subsystems, Crossbar's memory solutions aim to redefine the traditional constraints of flash and DRAM technologies, enhancing both edge and cloud computing capabilities. The company has garnered support from top-tier investors and boasts a team of experts dedicated to advancing memory technology.

Axonia Medical

Seed Round in 2014
Axonia Medical's proprietary approach is to repair and restore damaged peripheral or central nervous systems using tissue-engineered nerve grafts. They are expected to bridge lost nervous tissue and jump-start regenerative mechanisms to achieve levels of functional recovery not possible with current technologies.

Crossbar

Series C in 2014
Crossbar Inc. specializes in developing and licensing resistive RAM (ReRAM) technology, which offers innovative non-volatile memory solutions for various applications. Founded in 2008 and headquartered in Santa Clara, California, the company’s technology enables the storage of up to one terabyte of data on a chip the size of a postage stamp, providing high performance with low power consumption. Crossbar's ReRAM is designed for use in consumer electronics, mobile devices, enterprise storage systems, and IoT applications such as smart meters and industrial sensors. By allowing for integrated compute and storage subsystems, Crossbar's memory solutions aim to redefine the traditional constraints of flash and DRAM technologies, enhancing both edge and cloud computing capabilities. The company has garnered support from top-tier investors and boasts a team of experts dedicated to advancing memory technology.

Sonitus Medical

Series D in 2012
Sonitus Medical Inc. is a privately held medical device company based in San Mateo, California, focused on delivering innovative hearing solutions for patients with hearing difficulties. The company is recognized as an emerging leader in bone conduction hearing devices, particularly through its flagship product, the SoundBite Hearing System. This system is notable for being the world's first non-invasive and removable hearing solution, which transmits sound through the teeth, leveraging the principle of bone conduction. The device is FDA cleared as a prosthetic option for treating single-sided deafness and conductive hearing loss. Sonitus Medical aims to expand its technology for future applications, including mixed hearing loss and tinnitus, along with potential consumer and covert communication uses. Founded in June 2006, the company collaborates with otologists, ENTs, and audiologists to enhance the auditory experience for patients.

LectureTools

Grant in 2011
LectureTools is a web-based student response and learning environment that facilitates in-class communication between instructors and students with laptops and mobile phones. LectureTools began at the University of Michigan as a research project and is now a technology spinoff preparing for commercial launch. Our simple and intuitive interface enables the addition of interactivity to lectures. Independent research has since shown that LectureTools improves student engagement and attentiveness in large classes. During lecture, instructors can unhide slides and pose several types of student response activities to students. The Presentation Dashboard allows instructors to track student comprehension and receive notifications when students are struggling. The student inquiry channel allows students to ask questions possibly answered by teaching assistants in real-time, empowering even the least confident students to speak up. Answered questions are visible anonymously to the entire class, allowing students to learn from each other. LectureTools is run in the cloud and requires no special hardware, installation, or downloads. We provide instructors with a single system where they can upload lecture slides for your students to access. Students have a built in note-taking tool designed for the lecture environment, as well as the ability to bookmark slides for further review.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.